Reduced bile acid excretion is an independent risk factor for stroke and mortality: A prospective follow-up study

Gideon Charach1, Eli Karniel1, Ilya Novikov1

  • 1Department of Internal Medicine B, Meir Medical Center, Kfar Saba, Israel; Affiliated with Sackler Medical School, Tel Aviv University, Tel Aviv, Israel.

Atherosclerosis
|December 24, 2019
PubMed

Insights

Lower bile acid excretion (BAE) is linked to increased stroke risk. This finding suggests BAE may be an independent risk factor for stroke, even after accounting for other potential causes.

Area of Science:

  • Cardiovascular Medicine
  • Gastroenterology
  • Metabolic Disorders

Background:

  • Hypercholesterolemia is a significant risk factor for atherosclerosis, a primary cause of cardiovascular diseases including stroke.
  • Bile acid excretion (BAE) plays a role in cholesterol metabolism and may influence cardiovascular health.

Purpose of the Study:

  • To investigate the association between bile acid excretion (BAE) and the incidence of stroke.
  • To determine if BAE is an independent risk factor for stroke.

Main Methods:

  • A retrospective, historical cohort follow-up study was conducted on patients admitted for chest pain and suspected coronary artery disease (CAD).
  • Bile acid excretion (BAE) was evaluated using a 24-hour stool collection and a continuous, non-absorbable marker.
  • Patients were followed from 1998 to 2018 for stroke incidence and mortality.

Main Results:

  • Mean BAE was significantly higher in survivors compared to non-survivors (p<0.001).
  • Total BAE was significantly higher in stroke-free patients than in those who developed stroke (p<0.001).
  • Patients with low BAE (<262.4 mg/24h) had a 75% stroke incidence, while none with high BAE (>622 mg/24h) developed stroke.

Conclusions:

  • Lower amounts of total bile acid, deoxycholic acid, and lithocholic acid excretion are associated with increased stroke risk.
  • Low BAE was identified as a significant risk factor for stroke, potentially independent of other confounders.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
284
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
547
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
485
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.2K
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
313